Table 3 Basic characteristics of all subjects in validation cohort
From: Two-stage association study of mitochondrial DNA variants in allergic rhinitis
Variables | Total (n = 120) | Case (n = 69) | Control (n = 51) | p-value |
|---|---|---|---|---|
Age, median (Q1,Q3) | 33 (24, 46) | 35 (24, 46) | 31 (22, 46) | 0.294 |
Sex, n (%) | 0.860 | |||
Male | 67 (56%) | 39 (57%) | 28 (55%) | |
Female | 53 (44%) | 30 (43%) | 23 (45%) | |
IgE, median (Q1,Q3) | 53 (16, 190) | 148 (45, 299) | 16 (8, 29) | < 0.001 |
Family history, n (%) | < 0.001 | |||
No | 81 (68%) | 30 (43%) | 51 (100%) | |
Yes | 39 (32%) | 39 (57%) | 0 (0%) | |
Drug allergy, n (%) | 0.003 | |||
No | 98 (82%) | 51 (74%) | 47 (92.16%) | |
Yes | 21 (18%) | 18 (26%) | 4 (7.84%) |